

Craftsmanship Pharmaceuticals Kangda Sifang
10% glucose injection
General name: Glucose injection
English name: Glucose Injection
Chinese Pinyin: Putaotang Zhusheye
【Ingredients】
The main ingredient of this product is glucose, and its chemical name is: D-(+)-glucopyranose-hydrate.
Molecular weight: 198.17
Auxiliary material name: water for injection.
【System】
This product is a colorless or almost colorless clear liquid.
【Indications】
(1) Replenish energy and body fluids; used for insufficient food or loss of large amounts
【Drug name】
General name: Glucose injection
English name:Glucose Injection
Pinyin in Chinese:Putaotang Zhusheye
【Ingredients】
The main ingredient of this product is glucose, and its chemical name is: D-(+)-glucopyranose-hydrate.
Molecular formula:C6H12O6·H2O
Molecular weight:198.17
Name of auxiliary materials:Water for injection。
【Sexual】
This product is a colorless or almost colorless clear liquid。
【Indications】
(1)Replenish energy and body fluids; used for insufficient food or large amounts of body fluids caused by various reasons (such as vomiting, diarrhea, etc.), total intravenous nutrition, starvation ketosis;
(2)Hypoglycemia;
(3)Hyperkalemia;
(4)Hypertonic solution is used as tissue dehydrating agent;
(5)Prepare peritoneal dialysate;
(6)Drug diluents;
(7)Intravenous glucose tolerance test;
(8)For preparation of GIK (polarized liquid) liquid。
【Specification】(1)500ml:50g (2)250ml:25g (3)100ml:10g
【Adverse reactions】
(1)Phlebitis occurs when hypertonic glucose injection is injected. If large vein infusion is used, the incidence of phlebitis will decrease。
(2)Extravasation of high concentration glucose injection can cause local swelling and pain。
(3)Reactive hypoglycemia: combined with insulin overdose, the original tendency to hypoglycemia and the sudden stop of total intravenous nutrition therapy。
(4)Hyperglycemia non-ketosemia coma: more common in diabetes, stress state, use of a large amount of glucocorticoids, uremia peritoneal dialysis patients with hypertonic glucose solution and total nutrition therapy。
(5)Electrolyte disorders: Low potassium, low sodium and hypophosphatemia are prone to occur when glucose is only replenished for a long time。
(6)Those with original cardiac insufficiency。
(7)Hyperkalemia: Occasionally occur when patients with type I diabetes use high concentrations of glucose。
【Forbidden Taboo】
(1)Diabetic ketoacidosis uncontrolled;
(2)Hyperglycemia nonketozy hyperosmotic state。
【Storage】 Confined storage。
【Package】 Polypropylene infusion bottle 500ml×30Bottle/box 250ml×40Bottle/box 250ml×50Bottle/box
100ml×100Bottle/box 100ml×120Bottle/box
【Valid period】 24 months
【Implementation standards】Chinese Pharmacopoeia 2020 Edition Part Two
【Approval number】
Drug name | Specification | Approval number |
Glucose injection | 500ml:50g | National drug approvalH52020411 |
Glucose injection | 250ml:25g | National drug approvalH52020412 |
Glucose injection | 100ml:10g | National drug approvalH52020833 |
【Drug marketing authorization holder】/【Manufacturing enterprises】
Name:Guizhou Tiandi Pharmaceutical Co., Ltd.
address:No. 6 Baokang Road, Hongxing Pharmaceutical Industrial Park, Dingxiao Town, Xingyi City, Qiannan Buyi and Miao Autonomous Prefecture, Guizhou Province
postal code:562400
tel:0859-3119928
fax:0859-3118152
website:www.gztiandi.com

Copy product links
Long by picture save/share
enquiry form:
Inquiry Content:
You have no items to require
